Clover Health officer plans sale of 1,921 shares

Clover Health Investments, Corp. (CLOV) officer Jamie Reynoso filed a Rule 144 notice for a proposed sale of up to 1,921 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ.

Rhea-AI Filing Summary

Clover Health Investments, Corp. (CLOV) officer Jamie Reynoso filed a Rule 144 notice for a proposed sale of up to 1,921 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ. The shares to be sold were acquired on September 15, 2026 as Restricted Stock Units from the issuer.

Reynoso also reports several sales of Clover Health common stock in the prior three months, including transactions on July 6, July 8, July 15, July 17, and September 15, 2026, some of which were executed as 10b5-1 sales.

Key Figures

Planned shares to be sold: 1,921 shares Planned sale value: $8,759.76 Past sale on September 15, 2026: 9,273 shares for $44,324.94 +4 more

7 metrics

Planned shares to be sold 1,921 shares Common stock under current Rule 144 notice

Planned sale value $8,759.76 Aggregate market value for 1,921 shares in current notice

Past sale on September 15, 2026 9,273 shares for $44,324.94 Common stock sold by Jamie Reynoso in prior 3 months

Past 10b5-1 sale on July 17, 2026 4,839 shares for $21,908.57 Designated 10b5-1 sale of common stock

Past sale on July 15, 2026 13,119 shares for $61,265.73 Common stock sale in prior 3 months

Past 10b5-1 sale on July 8, 2026 2,384 shares for $11,153.07 Designated 10b5-1 sale of common stock

Past sale on July 6, 2026 6,229 shares for $32,764.54 Common stock sale in prior 3 months

Key Terms

Rule 144, Restricted Stock Units, 10b5-1, Executive Financial Services

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | | | 1921 | 09/15/2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 regulatory

"10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for CLOV by Jamie Reynoso report?

It reports that officer Jamie Reynoso filed a Rule 144 notice to sell up to 1,921 shares of Clover Health common stock, acquired as Restricted Stock Units on September 15, 2026 and to be sold through Morgan Stanley Smith Barney LLC on NASDAQ.

How many CLOV shares is Jamie Reynoso planning to sell under this Form 144?

The notice covers a proposed sale of up to 1,921 shares of Clover Health common stock, with an indicated aggregate market value of $8,759.76 for this planned transaction.

What is the nature and acquisition date of the CLOV shares to be sold?

The 1,921 shares of Clover Health common stock to be sold were acquired on September 15, 2026 as Restricted Stock Units from the issuer.

Which broker is handling Jamie Reynoso’s planned CLOV stock sale?

The planned sale of Clover Health common stock is listed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as the broker for the transaction.

What CLOV stock sales has Jamie Reynoso made in the past three months?

Disclosed past three-month sales include 9,273 shares for $44,324.94 on September 15, 2026, plus sales on July 17, July 15, July 8, and July 6, 2026, with several labeled as 10b5-1 sales.

Were any of Jamie Reynoso’s recent CLOV stock sales under a 10b5-1 plan?

Yes. Some entries are designated as 10b5-1 Sales, including a sale on July 17, 2026 of 4,839 shares for $21,908.57 and a sale on July 8, 2026 of 2,384 shares for $11,153.07.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 04:29 PM Accepted by SEC EDGAR 09/17/2026 - 04:29 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001839066
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clover Health Investments, Corp.
SEC File Number	001-39252
Address of Issuer	1209 Orange Street Wilmington DELAWARE 19801
Phone	2014322133
Name of Person for Whose Account the Securities are To Be Sold	JAMIE REYNOSO
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1921	8759.76	435441337	09/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/15/2026	Restricted Stock Units	Issuer			1921	09/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	09/15/2026	9273	44324.94
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	07/17/2026	4839	21908.57
JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	07/15/2026	13119	61265.73
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	07/08/2026	2384	11153.07
JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	07/06/2026	6229	32764.54

144: Remarks and Signature

Remarks
Date of Notice	09/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jamie Reynoso
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)